TrialPloS one2017

Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.

Verena Sailer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.